Replies to post #46633 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

All indications are pointing to Easton's intention to uplist yes.

"The completion of the iBliss acquisition and its sales has resulted in Easton looking to retain auditors for its intent on filing a Form 10 or S1 registration statement towards becoming a fully reporting issuer with the Securities and Exchange Commission."

Tweet is in reference to Pending Announcements from EAPH which are significant.